ESCP awards Nuri Okkabaz prestigious Lars Påhlman EBSQ medal

The European Society of Coloproctologists (ESCP) has awarded the Lars Påhlman EBSQ medal to Dr Nuri Okkabaz from Bağcılar Training and Research Hospital in Istanbul, Turkey. Nuri Okkabaz was awarded the Lars Påhlman medal at the 2018 ESCP meeting after obtaining the highest score in the 2017 European Board of Surgery Qualification (EBSQ) exam, during a ceremony at the ESCP’s annual meeting in France 2018.

ESCP launches new European School of Coloproctology

The European Society of Coloproctology’s (ESCP) Education Committee has launched a new training school to help surgeons continue their professional education and development in the latest techniques of their field - the European School of Coloproctology (ESC). The School will offer a series of training courses in topics such as laparoscopic complete mesocolic excision and creation of continent pouches and continent ileostomies.

Early-life gut microbiota could have lasting effect on ability to fight chronic diseases

New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes - the one-of-a-kind microbial communities that live in our gastrointestinal tracts - to help ward off serious chronic diseases. The discovery sheds new light on how these microbiomes, which are as personal as fingerprints, establish themselves and what drives their unique nature.

Colon cancer is associated with bacteria and cell stress

Researchers at Technical University Munich have reported colon cancer is caused by bacteria and cell stress, more specifically activated transcription factor ATF6 and that chronic inflammation has no effect on cancer development in the colon. It was known that ATF6 regulates stress in cells, and the intensity and duration of activation is increased with diseases. In this latest study, ATF6 incidence was found to be increased in colon cancer patients.

New nuclear medicine imaging method has potential for cancer imaging

A new nuclear medicine imaging method could help diagnose widespread tumours, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy, according to researchers from the University Hospital of Heidelberg and at the German Cancer Research Center. The paper, ‘A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts’, was published in Journal of Nuclear Medicine

Probiotics might not be effective for health in the human gut

New research suggests that probiotics might not be as effective as we think. Through a series of experiments looking inside the human gut, researchers found that many people's digestive tracts prevent standard probiotics from successfully colonising them. Furthermore, taking probiotics to counterbalance antibiotics could delay the return of normal gut bacteria and gut gene expression to their naïve state. The research publishes as two back-to-back papers in the journal Cell.

c-MYC protein contributes to the formation of adenomas in the colon

A new study carried out by a team led by Professor Heiko Hermeking at the Institute of Pathology at LMU (and German Cancer Consortium) shows that the regulatory protein c-MYC, which plays an important role in promoting the development of many types of tumours, induces the production of a transcription factor that increases the numbers of stem cells in the intestinal epithelium, and thereby contributes to the formation of adenomas in the colon.